NRIX
Nurix Therapeutics·NASDAQ
--
--(--)
--
--(--)
5.65 / 10
Netural
Fund flow metrics score 7.8/10, revealing robust fund flow characteristics. Beneficial no significant trends trends are challenged by problematic overall, block, Small, Medium, Large, and Extra-large signals, indicating positive capital movement. Analyst perspective reveals overwhelmingly bullish analyst consensus with strong conviction. Rating breakdown: Strong Buy(57.1%), Buy(42.9%) from 7 analyst assessments, supported by 3.51 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
57%
Buy
43%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-29
InstitutionRBC Capital
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for NRIX?
- NRIX holds a Bearish analyst rating, with 57% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.65/10 (Netural).
